Durham, NC – According to filings with the U.S. Securities and Exchange Commission, Reactive Biosciences is raising $40,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Julie Grant played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Reactive Biosciences
At Reactive, were using the worlds leading boron-based discovery platform to discover and develop medicines in innovative and imaginative new ways. By utilizing borons unique characteristics to access novel binding sites, were looking to advance therapeutics in areas previously thought to be undruggable. Our goal is to make impactful medicines that can truly change the course of disease and the lives of patients and their loved ones.

To learn more about Reactive Biosciences, visit http://www.reactivebio.com/

Contact:
Julie Grant, Chief Executive Officer
984-569-4261
https://www.linkedin.com/in/julie-grant-a8961b1/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved